Upcoming Meetings & Events
Society of Toxicology Meeting 2013
San Antonio, TX
Mar. 10-14th
Optivia Webinar: OAT Transporters in Hepatocytes
Dec. 17th
Registration here
Optivia Webinar: Transporter Biology for Discovery
Nov. 14th.
Click here to request slides.
Society of Toxicology Meeting 2013
San Antonio, TX
Mar. 10-14th
Optivia Webinar: OAT Transporters in Hepatocytes
Dec. 17th
Registration here
Optivia Webinar: Transporter Biology for Discovery
Nov. 14th.
Click here to request slides.
Offers the world's largest portfolio of drug transporter models
with collections available for multiple applications:
Drug-drug Interactions (DDI)
Toxicology
Drug Targeting
Drug Resistance
Pharmacology
Recent News
• December 2012: Optivia launches new website.
• November 2012: ITC2 Highlights published.
• October 2012: Optivia presents 2 posters at AAPS and 4 at ISSX.
• September 2012: Transporter Science Fall Newsletter released.
• August 2012: EMA finalizes DDI regulatory guidance.
• December 2012: Optivia launches new website.
• November 2012: ITC2 Highlights published.
• October 2012: Optivia presents 2 posters at AAPS and 4 at ISSX.
• September 2012: Transporter Science Fall Newsletter released.
• August 2012: EMA finalizes DDI regulatory guidance.
Optivia Biotechnology, Inc. is a contract research organization (CRO), offering drug transporter services to the pharmaceutical industry. We are the leaders in drug transporter technologies, and our scientific advisory board includes renown leaders in the field of drug transporter science. Optivia is located in California, with sales offices worldwide. Contact us to learn how to discuss how we can help your drug development or discovery programs.
